Suchergebnisse - "Hackman, Frances"

PubPharm (24)

1

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Participants Hospitalized With COVID-19

enthalten in: Open forum infectious diseases | 2023

von Robinson, P. | Toussi, S. | Aggarwal, S. | +20

2

Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy : A Novel Approach for Accelerating Drug Development

enthalten in: Clinical pharmacology and therapeutics | 2022

von Singh, R. | Walker, G. | Kadar, E. | +9

3

Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF-07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS-CoV-2, in Healthy Adult Participants

enthalten in: Clinical pharmacology in drug development | 2022

von Zhu, T. | Pawlak, S. | Toussi, S. | +8

4

Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID-19 Trial of Nirmatrelvir

enthalten in: Clinical pharmacology and therapeutics | 2022

von Singh, R. | Toussi, S. | Hackman, F. | +13

5

Innovative Randomized Phase 1 Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID-19 Trial of Nirmatrelvir

enthalten in: bioRxiv.org | 2022

von Singh, R. | Toussi, S. | Hackman, F. | +13

6

Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF‐07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS‐CoV‐2, in Healthy Adult Participants

enthalten in: Clinical Pharmacology in Drug Development | 2022

von Zhu, T. | Pawlak, S. | Toussi, S. | +8

7

Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir

enthalten in: Clinical Pharmacology & Therapeutics | 2022

von Singh, R. | Toussi, S. | Hackman, F. | +13

8

Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy : A Novel Approach for Accelerating Drug Development

enthalten in: Clinical Pharmacology & Therapeutics | 2022

von Singh, R. | Walker, G. | Kadar, E. | +9

9

Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury : An international collaborative effort

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Church, R. | Kullak-Ublick, G. | Aubrecht, J. | +20

CommentIn: Hepatology. 2018 Jun;67(6):2480-2481. - PMID 29500900

10

Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury : An international collaborative effort

enthalten in: Hepatology | 2019

von Church, R. | Kullak‐Ublick, G. | Aubrecht, J. | +20